Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
46.9
% (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)2024年3月1日〜2024年8月31日ConsolidatedJapanese GAAPNet Sales60,229¥ millionYear on year +46.9%Progress 49.9%
Operating profit17,146¥ millionYear on year +72.3%Progress 54.2%
Ordinary income20,574¥ millionYear on year +48.3%Progress 65.3%
Net income attributable to owners of the parent15,850¥ millionYear on year +61.2%Progress 69.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share89円97銭
Financial position at period-end
Total assets184,726¥ million
of which net assets 124,212 ¥ millionEquity ratio 60.6%vs. prior year-end +1.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueSemiconductor and FPD Equipment Business ¥59,895 million (YoY +46.7%), Life Sciences Business ¥334 million (YoY +118.7%)
Segment profitSemiconductor and FPD Equipment Business ¥17,609 million (YoY +71.0%), Life Sciences Business ¥-52 million
Regional sales¥5,723 million, ¥7,090 million, ¥25,115 million, ¥4,600 million, ¥14,868 million, ¥2,831 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥120,784 million (YoY +29.5%)
Operating profit¥31,617 million (YoY +31.0%)
Ordinary income¥31,518 million (YoY +16.4%)
Net income¥22,916 million (YoY +17.1%)
Annual Dividend Forecast135 Yen (prior-year actual on a pre-stock-split basis; current-year forecast on a post-stock-split basis) → 16 Yen (prior-year actual on a pre-stock-split basis; current-year forecast on a post-stock-split basis)
Factors Behind Changes in Business Performance
半導体需要の回復と在庫の正常化、生成AI関連の先端半導体需要の回復、中国の半導体製造拠点増強に伴う中国向け装置需要の増加。
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 1 / Company name Nanoverse Technologies,Ltd. / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent events2024年9月1日付で普通株式1株につき10株の割合で株式分割を実施。
Orders received and order backlogOrders received ¥52,070 million (YoY +128.8%) / Order backlog ¥59,723 million (YoY +93.1%)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Institutional investors and analysts
Issued Shares at Period-End176,400,000株
Treasury Shares at Period-End42,860株
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年3月1日〜2024年8月31日 |
| Net Sales | ¥60,229 million (YoY +46.9%) |
| Operating profit | ¥17,146 million (YoY +72.3%) |
| Ordinary income | ¥20,574 million (YoY +48.3%) |
| Profit attributable to owners of the parent | ¥15,850 million (YoY +61.2%) |
| Net income per share | 89円97銭 |
| Equity ratio | End of the current fiscal period 60.6 / End of previous period 59.1 |
| Total assets | ¥184,726 million |
| Net assets | ¥124,212 million |
| Full-year earnings forecast | Net Sales ¥120,784 million (YoY +29.5%) / Operating profit ¥31,617 million (YoY +31.0%) / Ordinary income ¥31,518 million (YoY +16.4%) / Net income ¥22,916 million (YoY +17.1%) |
| Annual Dividend Forecast | 135 Yen (prior-year actual on a pre-stock-split basis; current-year forecast on a post-stock-split basis) → 16 Yen (prior-year actual on a pre-stock-split basis; current-year forecast on a post-stock-split basis) |
| Segment revenue | Semiconductor and FPD Equipment Business ¥59,895 million (YoY +46.7%), Life Sciences Business ¥334 million (YoY +118.7%) |
| Segment profit | Semiconductor and FPD Equipment Business ¥17,609 million (YoY +71.0%), Life Sciences Business ¥-52 million |
| Regional sales | ¥5,723 million, ¥7,090 million, ¥25,115 million, ¥4,600 million, ¥14,868 million, ¥2,831 million |
| Orders received and order backlog | Orders received ¥52,070 million (YoY +128.8%) / Order backlog ¥59,723 million (YoY +93.1%) |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name Nanoverse Technologies,Ltd. / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | 2024年9月1日付で普通株式1株につき10株の割合で株式分割を実施。 |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 176,400,000株 |
| Treasury Shares at Period-End | 42,860株 |
| Factors Behind Changes in Business Performance | 半導体需要の回復と在庫の正常化、生成AI関連の先端半導体需要の回復、中国の半導体製造拠点増強に伴う中国向け装置需要の増加。 |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyDepreciation and amortizationImpairment lossBreakdown of extraordinary income (loss)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.半導体需要の回復と在庫の正常化、生成AI関連の先端半導体需要の回復、中国における半導体製造拠点の増強に伴う中国向け装置需要の増加。通期予想については、売上高が予想通りに推移し、利益も予想数値に大きな乖離がないため変更しないとしている。なお、Nanoverse Technologies,Ltd.の連結子会社化により販売費及び一般管理費が約35億円増加する見込み。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.